Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I [Phase 4]
The MINT I trial, a multi-institutional Phase 4 study evaluating neo-adjuvant therapy guided by the MammaPrint assay in breast cancer, has b…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer [Phase 1, Phase 2]
An update on a Phase 1/Phase 2 trial evaluating intravenous ascorbic acid supplementation in neoadjuvant chemotherapy for breast cancer; the…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain [Phase 2]
Phase 2 trial of pregabalin for G-CSF-induced bone pain in patients with breast cancer or lymphoma was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Vitamin D and Breast Cancer Biomarkers in Female Patients [Phase 3]
Phase 3 trial investigating the effect of vitamin D on biomarkers in female breast cancer patients. The study is completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients [NA]
This completed clinical trial evaluated whether herbal products can reduce radiation-induced dermatitis in breast cancer patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Non-interventional Study With Nab-Paclitaxel (Abraxane®)
This is a completed non-interventional study evaluating nab-paclitaxel (Abraxane) in patients with metastatic breast cancer. The update indi…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer
Pilot study update evaluating patient adherence to lapatinib (TYKERB/TYVERB) plus capecitabine in metastatic breast cancer; the trial sponso…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
A completed clinical trial evaluating biomarker profiles in Asia Pacific HER2-positive breast cancer patients treated with lapatinib.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer [NA]
A completed trial comparing contrast-enhanced mammography to breast MRI for screening women at increased risk of breast cancer. The study ev…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System [NA]
A clinical trial update for Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System evaluating breast cancer; the s…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Breast Cancer Long-term Outcome of Cardiac Dysfunction
An update detailing the long-term cardiac outcomes observed in breast cancer patients enrolled in the NCT01904331 trial.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer [Phase 1]
Phase 1 study evaluating ganetespib with paclitaxel, trastuzumab, and pertuzumab in metastatic HER2-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Tracking Physical Activity Throughout Chemotherapy for Breast Cancer
A completed clinical trial tracking physical activity levels in patients undergoing chemotherapy for breast cancer, focusing on activity mon…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC) [Phase 1]
This document reports the completion of a Phase 1 dose-finding study evaluating pertuzumab in combination with trastuzumab in healthy male p…
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Project MOVE: Increasing Physical Activity Among Breast Cancer Survivors [NA]
Project MOVE, a University of British Columbia trial aimed at increasing physical activity among breast cancer survivors, has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Application of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer Research [NA]
This update reports on a completed clinical trial evaluating a surgical navigation system for identifying sentinel lymph nodes in breast can…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer [Phase 2]
Phase 2 study evaluating IMC-A12 (cixutumumab) alone or in combination with antiestrogens for metastatic breast cancer has completed, with r…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization [EARLY_Phase 1]
A Phase 1 trial evaluated a 99mTc-labeled Affibody imaging agent for HER2 characterization in breast cancer using SPECT/CT. The study has co…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer
This update reports on a completed clinical trial evaluating whether a structured physical activity program influences aging-related biomark…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer [Phase 2]
Phase 2 trial update of alisertib (MLN8237) in ovarian, fallopian tube, or peritoneal cancer following a prior MLN8237 plus paclitaxel Phase…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Radiofrequency Ablation in Breast Cancer [NA]
A clinical trial evaluating radiofrequency ablation for breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Use of the Venous Coupler in Breast Reconstruction by Means of a Deep Inferior Epigastric Perforator: Reduction of Surgery Length and Venous Thromboses ?
A completed clinical trial evaluating the use of a venous coupler in Deep Inferior Epigastric Perforator (DIEP) flap breast reconstruction, …
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery [Phase 2]
Phase 2 trial evaluating cyclophosphamide and paclitaxel with or without trastuzumab in surgically treated stage I-II breast cancer; trial c…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer [Phase 2]
Clinical trial update noting the completion of a Phase 2 study evaluating a psychosexual intervention in patients with Stage I-III gynecolog…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Early Rehabilitation After Immediate Reconstruction With TEI in Breast Cancer Patients
This clinical trial update reports the completion of a study evaluating early rehabilitation after immediate reconstruction using TEI in pat…